Shows
Grow Everything Biotech Podcast151. Report on Reports: Cash Flow, Carbon, and the BioeconomyIn this episode, Erum and Karl unpack six major reports that define the current state of synthetic biology and the bioeconomy. From investment trends to national security concerns, from manufacturing failures to trillion-dollar opportunities, these reports paint a complex picture of an industry at a critical turning point.Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders and influencers changing the world by growing everything. Biology is the oldest technology. And it can be engineered. What are we growing?Learn more at www.messaginglab.co...
2025-10-1749 minGrow Everything Biotech Podcast130. SynBioBeta 2025 Recap: Hyperscale BiologyIn this energetic recap of SynBioBeta 2025, Erum and Karl bring listeners straight into the heart of the year’s most important synthetic biology gathering. From Drew Endy’s visionary keynote on distributed, localized manufacturing to the ever-present theme of AI as the enabler of hyperscale biology, this episode unpacks the biggest ideas shaping the future of biomanufacturing and materials innovation. The duo reflect on how the conference architecture—from hallway conversations to main stage moments—facilitated cross-disciplinary collisions and bold discussions about biology as the foundational infrastructure of the 21st century. Whether you're a bioengineer, startup founder, or investor, this deb...
2025-05-231h 00Grow Everything Biotech Podcast128. Replay of Synbiobeta 2024 Recap with Fresh CommentaryKarl and Erum revisit their energetic and unfiltered recap of SynBioBeta 2024. With candid reflections on the conference and the broader synthetic biology ecosystem, they spotlight key trends including the rise of accessible community bio labs, decentralized events like the Biopunk gathering, and the convergence of deep tech and culture. This is not your average event recap—it's a tour through the evolving architecture of the bioeconomy, from the mainstream to the fringes. Whether you missed the event or want to relive the highlights, this episode captures the pulse of where biotech is heading.Grow Everything brings the bi...
2025-05-091h 18Grow Everything Biotech Podcast127. Chain Reaction: Orchestrating BioInnovation Without Missing a Beat – with MessagingLab’s Erum & KarlErum and Karl break down a concept they've lived and breathed—but rarely spelled out: orchestration. If you're building a startup in synthetic biology or advanced materials, this is a must-listen deep dive into how influence is built before your product lands or your funding closes. They pull back the curtain on how to create "value chain syndicates," why intros aren’t just intros, and how real biotech momentum comes from aligning stakeholders across an entire ecosystem—not just impressing one customer.Taped just ahead of SynBioBeta 2025, this episode crackles with tactical wisdom, from designing credibility scaffolds to cre...
2025-05-0222 min
The Bio ReportSynbio Companies Come to Grips with the One “Omic” that MattersSynthetic biology companies have faced a difficult few years as share prices have been battered and investment in the sector has waned. As investors and companies are readying to gather for the annual SynBioBeta conference in San Jose May 5 through 8, a new report from the bipartisan National Security Commission on Emerging Biotechnology warns that the United States is at risk of losing its leadership to China and is calling for a $15 billion investment into biotech over the next five years to support startups that strengthen national security. We spoke to John Cumbers, founder and CEO of SynBioBeta, about the...
2025-04-2334 minGrow Everything Biotech Podcast125. The Synbio Symphony: SynBioBeta’s John Cumbers Harmonizes Biology and IndustryKarl and Erum welcome back Dr. John Cumbers—founder of SynBioBeta and Biological Enlightenment Studios—to dive deep into the transformative power of synthetic biology. From designing personalized proteins and sustainable materials to programming life for space exploration, John unpacks why synthetic biology could be the defining technology of our century. The conversation spans the central dogma, programmable cells, AI-designed genomes, and even the ethics of growing brainless human clones. With themes ranging from planetary health to Pixar-style science storytelling, this episode offers a biologically enlightened vision of a future where we grow everything—from meat to materials to machin...
2025-04-181h 03
BioTech Nation ... with Dr. Moira GunnThe Future of Synthetic Biology... Dr. John Cumbers, Founder & CEO, SynBioBetaThis week on BioTech Nation, I speak with Dr. John Cumbers, founder and CEO of SynBioBeta, the annual synthetic biology conference. We discuss how biology, AI, and technology are transforming industries, covering tracks on human health, planetary health, and hyperscale biology. SynBioBeta 2025 will take place in San Jose, CA, from May 5 to 8.
2025-04-0218 min
Mendelspod PodcastSynthetic Biology Ready for Its ChatGPT Moment: A Preview of SynBioBeta 2025 with John CumbersJohn Cumbers, founder of SynBioBeta, joins Theral for our annual look ahead at the field of synthetic biology and the upcoming SynBioBeta 2025 conference, happening May 6–9 in San Jose. It's obviously a big year for AI, and synthetic biology is no exception. As John puts it, “Biology and AI coming together represents a huge opportunity for us to be able to understand biology and then ultimately engineer biology.” This year’s conference features a strong emphasis on AI's role in scaling and accelerating biological engineering, from foundational research to applied biotechnology.While synthetic biology is full of exciting opportun...
2025-04-0137 minGrow Everything Biotech Podcast77. AI x Biotech, Psychedelics, Mars and more at Synbiobeta 2024!!Episode Description:
Karl and Erum bring you the latest innovations highlighted at SynbioBeta 2024, focusing on the exciting intersection of AI and biotechnology. Hear about the groundbreaking work from the ARC Institute in whole genome sequencing and the newest advancements in AI-driven protein synthesis that are set to change the landscape of synthetic biology. They also touch on the potential of bioluminescent plants and the latest progress in space biomanufacturing. With expert insights and firsthand accounts from the conference, this episode offers a glimpse into the future of biotech and AI, sparking curiosity and excitement for what's to...
2024-05-171h 02
The SynBioBeta PodcastScaling New Heights in Biomanufacturing - with Edward ShenderovichOn this SynBioBeta podcast, John Cumbers talks with Edward Shenderovich, the Founder and CEO of Synonym, a company creating bioeconomy infrastructure to help next-generation bioproducts scale and get to market. Edward will speak at this year’s SynBioBeta conference on “Scaling Biological Capacity,” and in today’s episode, John and Edward will discuss how Synonym addresses some of the challenges in biomanufacturing with its technology-driven products and focus.
Edward Shenderovich is the founder and CEO of Synonym, which provides startups with a way to value the feasibility of their technology and effectively de-risk scalability. Edward has extensive experienc...
2024-04-1757 min
Smart Business Revolution | Turn Relationships into Revenues | Networking | More Clients | Relationship AdviceFuture of Synthetic Biology and Business by Dr. John CumbersDr. John Cumbers is the Founder and CEO of SynBioBeta, a vibrant community and conference centered around the synthetic biology field. With a background in molecular biology, biochemistry, and bioinformatics, including a stint at NASA, he made a dramatic leap from science to creating a thriving industry community. Dr. Cumbers' efforts at SynBioBeta have led to an annual conference attracting thousands of global participants, whereas as a dedicated connector, he passionately facilitates introductions that result in significant scientific advancements. He retains a robust academic background with a PhD in molecular biology, yet his childhood entrepreneurial spirit has fundamentally shaped...
2024-04-1237 min
Mendelspod PodcastSynthetic Biology in 2024 with John CumbersJohn Cumbers is back on the show to preview the annual SynBioBeta, the leading global conference for the synthetic biology crowd. This year’s show includes 18 tracks on AI, space, longevity, and DNA synthesis. Speakers will include Stephen Wolfram and Stephen Quake, who will discuss large language models and biology.While 2024 saw a total investment of over $6 billion (not as high as the pandemic year of 2021), John says the new technologies and startups keep coming."We’re seeing just a ton of new entrepreneurs coming out of graduate and undergraduate programs and starting companies.”John...
2024-03-2625 minThe SynBioBeta PodcastMycelium Magic: Crafting a Greener Future - with Eben BayerOn this SynBioBeta podcast, John Cumbers talks with Eben Bayer, the CEO of Ecovative, a pioneering company at the forefront of developing sustainable materials using mycelium. John and Eben will discuss Ecovative’s journey toward creating a billion pounds of mycelium, explore some of the cutting-edge agricultural technology used in mushroom growing, and discuss the transformative potential of new mycelium crops in consumer goods. Additionally, John and Eben will dive into Ecovative’s unique use of AI and digital twins.
Eben Bayer is the CEO of Ecovative, a pioneering company at the forefront of developing sustainable materials usin...
2024-02-1649 minGrow Everything Biotech Podcast62. Microbes, Memes and Missions to Mars: John Cumbers' Wild Synbio WorldEpisode Description:
How can biotechnology transform the world and beyond? That's the question that John Cumbers, a biotech visionary and entrepreneur, explores in this episode of the podcast. He reveals how biotechnology is merging with other sectors, such as space exploration, and how synthetic biology is reshaping the future. He also discusses how biotech can help solve global problems, from environmental to health issues. He shares his insights on the latest trends and innovations in biotech, such as AI and decentralized science, and how they are creating new possibilities and challenges. He also tells his story, from...
2024-02-0258 minGrow Everything Biotech Podcast58. Beyond Outsourcing: Erum Discovers India's Not Just Playing Lab AssistantEpisode Description:
Karl and Erum, discuss the nuances of India's biotech scene, highlighting its innovative ventures and the unique challenges they face. They uncover insights from key players in the industry and discusses the global implications of India's biotech advancements. They shed light on the fascinating concept of 'Juggad' – a creative problem-solving approach prevalent in Indian startups. This episode is a must-listen for anyone interested in the intersection of technology, entrepreneurship, and global biotech trends.
Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and interview the leaders an...
2024-01-0527 minThe SynBioBeta PodcastAI in Action: Synthesizing the Future of Drug Discovery - with Sean McClainOn this SynBioBeta podcast, John Cumbers talks with Sean McClain, founder, and CEO of Absci, a generative AI drug creation company on a mission to create better drugs for patients faster. Sean and John will continue some of the discussion that we started on the SynBioBeta stage around generative AI and its critical role in drug discovery, some news from AbSci’s recent R&D day, and Sean’s recent visit to Congress to discuss the opportunities and threats from AI and bio.
Sean McClain is the Founder and CEO of Absci, which he built from a base...
2023-12-0554 minGrow Everything Biotech Podcast52. Thanksgiving Replay: Orbillion’s Better For You BeefEpisode Description:
Karl and Erum are joined by Gabe and Samet to discuss alternative proteins and the meat market. They highlight the significance of storytelling in biotech to expand the market and the role of early adopters in this process. The conversation touches on the environmental impact of animal agriculture and the advantages of alternative protein sources. The group explores how technology can revolutionize the availability of premium products in the mass market and shares insights on the initial launch strategy through partnerships and food service. They also delve into the possibilities of culturing extinct and unique...
2023-11-2457 min
SOSV Climate Tech Podcasts03e15 - Solugen: Reinventing The Means Of Production, With EnzymesIn this interview from the 2023 SOSV Climate Tech Summit (Sept 26-27, 2023), Dr. Gaurab Chakrabarti, Co-founder and CEO of Solugen, a company specializing in sustainable chemicals, is interviewed by Dr. John Cumbers, Founder and CEO of SynBioBeta.
They discuss Solugen’s progress in fundraising and building infrastructure, as well as its focus on developing climate-neutral and climate-negative chemicals. They talk about the industrial uses of Solugen’s products, such as disinfecting water in agriculture and industrial water treatment. They also discuss the climate impact of its chemicals and their goal to replace 30% of US chemical demand with domestically bio...
2023-10-1924 min
Cognixia PodcastWhat is the future of bioengineering?Hello everyone, and welcome back to the Cognixia podcast. First, let us understand what bioengineering is. Bioengineering is the application of the principles and design concepts of engineering to the study & manipulation of biological systems and the development of biological products. It is a broad field of study that includes a very wide range of disciplines from biomedical engineering to agricultural engineering and bioprocess engineering to environmental engineering. Bioengineering is a rapidly advancing field with varied applications. Bioengineering professionals are playing a crucial role in improving human health and well-being for mankind globally.
Innovations...
2023-10-0707 min
Farrel Buchinsky's Listen LaterLeaps by Bayer & Ada Health Podcast: Built with Biology: SpacesEpisode: Leaps by Bayer & Ada HealthPub date: 2021-09-22Notes from Farrel Buchinsky's Listen Later:ada healthGet Podcast Transcript →powered by Listen411 - fast audio-to-text and summarizationLeveraging patient data looks to play a very significant role in improving disease prevention and treatment, giving medical professionals more time for their patients, and spotting health trends in populations before they reach epidemic levels.
But fulling realizing the potential of patient data is not without challenges. Naveen Krishnan of Le...
2023-06-2457 min
Translating AgingSynergizing Synbio & Longevity: A Panel Discussion at SynBioBeta 2023This special episode features a panel discussion moderated by Chris Patil at the 2023 SynBioBeta conference. The panel brings together leaders from the synthetic biology and longevity communities to explore opportunities for collaboration and cross-pollination between these fields. Panelists discuss the talent bottleneck in longevity research, challenges in translating new discoveries into therapies, the need for improved communication and education, and a shared vision for transforming health and society. The conversation covers existing resources for learning about longevity science, as well as calls to build new communities and networks to accelerate progress. Overall, the panel makes a compelling case that...
2023-05-3142 minGrow Everything Biotech PodcastHello From Oakland. We're Schmoozing at SynBioBeta. BRB.Episode Description:
In this episode of the Grow Everything podcast, Karl and Erum discuss the exciting advancements in biotech and highlight key moments from previous episodes. They emphasize the importance of sustainable practices and the positive impact biotechnology can have on the environment. They invite listeners to tune in to their podcast and recommend episodes featuring guests who discuss the intersection of biology with climate, clean-up technologies, cannabis, and dreaming in biology. It's an episode that showcases the potential of biotechnology and provides listeners with a curated list of episodes to explore.
Grow Everything brings to life...
2023-05-2603 minGrow Everything Biotech Podcast26. Breaking Bad Hair Habits with Biology: Suveen Sahib's K18 Rescues Your StrandsEpisode Description:
In this episode of Grow Everything, Karl and Erum interview Suveen Sahib, the founder of K18 Hair, a biotech-forward hair care company. They explore the intersection of biotechnology and the hair care industry, emphasizing the need for innovative solutions that work with human biology. They also discuss the long-term effects of heat tools on hair health and the potential of biotechnology to minimize damage and achieve straight hair. The hosts provide valuable tips on building relationships at conferences like Synbiobeta and highlight the Science and Entertainment Exchange's role in promoting accurate science in media.
2023-05-1957 minGrow Everything Biotech Podcast25. From Lab to Table: Meat Orbillion's Better-For-You BeefEpisode Description:
In this episode of the Grow Everything podcast, hosts Karl and Erum are joined by Gabe and Samet to discuss alternative proteins and the meat market. They highlight the significance of storytelling in biotech to expand the market and the role of early adopters in this process. The conversation touches on the environmental impact of animal agriculture and the advantages of alternative protein sources. The group explores how technology can revolutionize the availability of premium products in the mass market and shares insights on the initial launch strategy through partnerships and food service. They also...
2023-05-121h 00
The Bio ReportGrowing the BioeconomyWhile many people think of biotechnology in terms of its impact on medicine, it’s expected to transform the economy as its power reaches across industries. As biology increasingly becomes an engineering discipline, it is not only reshaping the way we produce food, but a wide range of industrial products as well. Bio-based processes are replacing petroleum-based ones and giving life to new biomaterials, bioplastics, and biofuels. As the SynBioBeta Global Synthetic Biology Conference returns to Oakland, California May 23 to May 25, we spoke to SynBioBeta Founder and CEO John Cumbers, about the state of the emerging bioeconomy, how biotechnology is...
2023-05-1032 min
Mendelspod PodcastBiden, AI, and DeSci: John Cumbers Previews SynBioBeta 2023SynBioBeta is the largest gathering of the synthetic biology community worldwide. It’s taking place May 23-25 in Oakland, California. John Cumbers is the founder and CEO of the conference, and he joins us to talk about trends in the space and preview this year’s confab.First, we discuss the impact Washington D.C. is having on the field. What doe’s Biden’s love for bio mean for synbio? This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe
2023-05-0939 min
Stranded Technologies PodcastEp. 46: John Cumbers on Synthetic Biology ("Synbio") - The Language of Life, Computational Biology & the Quest to Genetically Engineer the Organic WorldToday is the 70th anniversary of the discovery of the structure of DNA, and the 20th anniversary of the sequencing of the human genome.A perfect day to talk to John Cumbers.John is a molecular biologist. He is the founder and CEO of SynBioBeta which promotes synthetic biology to build a more sustainable universe.This episode is a primer on "synbio", the scientific breakthroughs and commercial applications of reading, sequencing and editing DNA to engineer the built world around us by manipulating the organic process of biology.
2023-04-261h 04
Space TalksMeet Elliot RothElliot is the founder of Spira, a company that creates replacements for animal and petroleum compounds in the supply chain using genetically engineered algae. He has presented at SXSW, Synbiobeta and Thought for Food. Elliot is a Kairos, Future Founders and Halcyon Fellow, a Seasteading Ambassador, and sat on the Virginia Governor's Council for Youth Entrepreneurship. Before Spira, Elliot graduated with a degree in biomedical engineering. He trained at the Stanford School, studying synthetic biology for 12 years and worked for 5 years as a product consultant. In his spare time, Elliot plays music and is working on side project to...
2023-04-1334 min
Celestial CitizenAll-In on Algae: A Greener Approach to Space NutritionOn today's episode, we’ll begin a special series that follows a month-long algae diet experiment with Founder of Spira, Elliot Roth, to explore the viability of algae as a food source in space. We’ll be following his journey from beginning to end, while helping to document reactions, findings, and even the emotions that come with committing to a space-age diet.Elliot is the Founder of Spira, a company that engineers algae for sustainable, healthier, and cost-effective industry applications. After being trained as a University Innovation Fellow at the Stanford d.School, Elliot started multiple entrepreneurial projec...
2023-03-2359 min
Grow Everything Biotech Podcast12. Oral Microbes, New Religion and a Galactic Takeover. Introducing John Cumbers.Episode Description:
This week on "Grow Everything," the hosts delve into the world of synthetic biology with guest John Cumbers, a tech background professional and entrepreneur with a passion for starting a biotech company. John hails from England and is married to a Malaysian. During the show, the team discusses the exciting possibilities of engineering bacteria for various applications, such as cleaning teeth without the need for traditional dental hygiene practices, and revenue models that leverage subscription-based models. They also touch on the crucial role of innovation in the field and the impact of monopolies on progress...
2023-02-1148 min
Science Metaverse PodcastEP 48: JPM Recap, no more mice trial requirements, generative ai proteins, GPCR, and morehttps://www.science.org/content/article/fda-no-longer-needs-require-animal-tests-human-drug-trialshttps://blogs.nvidia.com/blog/2023/01/12/generative-ai-proteins-evozyne/https://twitter.com/PDBeurope/status/1613121823452839936https://seekingalpha.com/news/3924363-structure-therapeutics-formerly-known-as-shoutti-files-for-100m-us-ipoSpecial thanks to Wuxi AppTec SynBioBeta, LatchBio, and Vial for their JPM events!
2023-01-1629 min
The Fancy Labcoat Guild"Go outside and touch grass!" Synthetic Biology, Community Building and Biohacking with Esther KimEsther Kim is a scientist working in synthetic biology. But she isn’t just a scientist, she’s a premiere community builder in these burgeoning scientific spaces. She has worked at small start-ups in the Bay Area at The ODIN, Synbiobeta, Braid Theory, and spent her early years working as a genetic engineer in biomanufacturing. She is most known for her work championing independent scientific researchers in the biohacking community to disrupt and transform scientific research and communication. She believes that science should be accessible and affordable to all.Join us as we talk about everything from comm...
2022-11-241h 32
Built with Biology: PodcastHow Will DNA Make Our Future?DNA powers the bioeconomy. These fundamental molecules enable us to re-program cells to produce sustainable materials and medicines. But reprogramming cells requires specific sequences of DNA that don't exist in nature--we have to make them ourselves. If that sounds easy, this episode will change your mind!
Thomas Ybert, co-founder and CEO of DNA Script joins the show for a brilliant discussion on how we make DNA, what role it plays in COVID testing, producing DNA in future outbreak zones, DNA data storage and the impending Armageddon of Data.
2022-08-2442 min
Greenhero#17 – Cell-based oysters on a half shell w/ Founder of Perlita Foods Nikita MichelsenThanks for joining us on the Greenhero Podcast with your host, Rikard Bjorkdahl! On the show today is Nikita Michelsen, founder and CEO of cell-based company Pearlita Foods. Driven by her passion for human health and reversing climate change, Nikita decided to launch her company to build the future of seafood. Nikita and her team are on a mission to grow the universally loved oyster in a lab environment. In this way, we can keep more oysters in the ocean as nature's own filtration system to clean water.Pearlita Foods was f...
2022-08-1725 minBuilt with Biology: PodcastProgram a Cell, Cure a Disease: Meet the Future of MedicineWhat if we could create any cell in the human body? Imagine the diseases we might treat, the bones we could heal, and the nerves we could repair. One day, we might even be able to replace blood banks. This future is much closer than you might think.
Mark Kotter, the founder and CEO of bit.bio joins the show for an inspiring discussion about how breakthrough technologies could offer hope to patients with untreatable conditions and what the future of medicine could look like.
2022-03-2340 minBuilt with Biology: PodcastDeep Tech and Synthetic Biology - The Big PictureWe know life is busy - it's a challenge to keep up with the biggest trends and technologies shaping our world. So we've edited this special episode to give you the snapshot you need to understand what Deep Tech is, its role in synthetic biology, and how these technologies could build our future.
On the go? No problem! Here's all you need to know in 20 minutes.
From the Deep Tech Mission at Boston Consulting Group, John Paschkewitz (Partner and Associate Director) and Nico Goeldel (Project Leader) join the show for a special look into the...
2022-02-1422 minBuilt with Biology: PodcastMeet the Future: Deep Tech and SynBio"Deep Tech," today's hottest technology buzzwords. But what is deep tech? How does it relate to building with biology? What will it take for deep tech innovations to make a positive impact in our world?
From the Deep Tech Mission at Boston Consulting Group, John Paschkewitz (Partner and Associate Director) and Nico Goeldel (Project Leader) join the show for a special look into the technological forces, mindsets, and challenges shaping our future.
2022-01-2541 minBuilt with Biology: PodcastHow Do We Design Biology? Get Ready to Be Surprised!Biology is spectacularly complex. Even when we think we know which genes produce and control which proteins, we find out there are entire sections of the genome we still don’t understand! So, what kind of mindset does it take to find the solutions to problems that have infinite answers?
Patrick Westfall, Senior Director of the Microbe Group at Inscripta, joins to show to explore rational versus irrational biology design and share the tools and mindsets that can help us build more successfully with biology!
2022-01-1937 min
Built with Biology: SpacesNeubase TherapeuticsAlmost every human disease is driven by genetics. So what if we could cure every genetic disease, from Alzheimer's to cancer?
These may sound like lofty aspirations. But the team at Neubase Therapeutics has developed a method for temporarily modifying disease-causing genes without permanently altering the genome. The backbone of Neubase's technology is also highly adaptable. If successful, the company could only need to make small tweaks to develop a brand new therapy, avoiding years of difficult and expensive clinical trials.
Tune in to hear more about Neubase's cutting-edge approach and much more!
...
2021-10-1134 minBuilt with Biology: PodcastWhat Makes CRISPR Like a Movie Star?CRISPR gene editing is one of the greatest scientific breakthroughs of the 21st century. But how does it work and what can it do? What kind of power--and responsibility--comes with the ability to edit 10,000 genes?
Nandini Krishnamurthy, the VP of Microbial Business Area at Inscripta, joins the show for a vision-casting episode about what we can build with CRISPR, from sustainable food production to advanced medicines, equitable distribution of resources, and, of course, Oscar-winning movies starring Meryl Streep! Tune in to get inspired for all that we can build with biology.
2021-09-2933 minBuilt with Biology: SpacesLeaps by Bayer & Ada HealthLeveraging patient data looks to play a very significant role in improving disease prevention and treatment, giving medical professionals more time for their patients, and spotting health trends in populations before they reach epidemic levels.
But fulling realizing the potential of patient data is not without challenges. Naveen Krishnan of Leaps by Bayer and Daniel Nathrath of Ada Health discuss integration challenges, patient privacy, the promise of better drug trials, and much, much more!
Want to ask your question live in one of our shows? Be sure to follow @SynBioBeta! #builtwithbiospaces
Keep in...
2021-09-2257 minBuilt with Biology: PodcastWhat Makes a Microbe a Superhero?What gives microbes superpowers? Can we program them as easily as we do computers? What could our world look like if microbe cell factories replaced petrochemical production?
Ena Cratsenburg, the Chief Business Officer of Ginkgo Bioworks, joins the show to answer these questions and explore what a world built with biology could look like. Ginkgo, the bioeconomy's original unicorn company, is leveraging its platform to give scientists creative freedom and accelerate innovation. Our planet needs outside-the-box solutions as quickly as possible. So it's a good thing Superhero Microbes are suited up and ready to go!
2021-09-2241 minBuilt with Biology: SpacesWild Earth: Ryan BethencourtGoing plant-based is one of the best things we can do for the health of our planet. But what about our pets? In the United States, pet food is responsible for 25-30% of the meat industry's environmental footprint. How can we reduce this negative impact while giving our beloved pets the best nutrition?
Meet Wild Earth, a company feeding pets sustainably with fermented koji, veterinary insight, cell culture, and most importantly, a love of animals! Did you know dogs are omnivores? Did you know you could soon have cell culture chicken for your cats? Tune in to...
2021-09-1644 minBuilt with Biology: PodcastHow Can We Welcome Everyone to the Bioeconomy?The bioeconomy--the growing economy built with biology--may sound unwelcoming if you don't have a biology degree. The beauty of the bioeconomy is that we are all needed to create a sustainable future, from artists to marketers to engineers, and especially entrepreneurs.
But how do we welcome everyone and inspire the next generation?
In a special episode, Jaye Goldstein of Petri and Natalie Kuldell of BioBuilder share their insights on creating community, supporting women and underrepresented genders, and how we can inspire the next generation on their journey from classroom to founder.
2021-09-1543 minBuilt with Biology: SpacesCemvita Factory: Tara Karimi and Moji KarimiToday, CO2 emissions from heavy industries are poisoning our atmosphere and causing climate change. But what if we could capture those CO2 emissions and transform them into valuable products using microbes?
That's exactly what the team at Cemvita Factory is doing! Based in Houston, the company has engineering microbes to turn carbon into useful products like bioethylene, just like how plants turn CO2 into oxygen through photosynthesis.
Tune in to hear from Cemvita's founders about how we can use CO2 as a feedstock in our energy transition to Net Zero.
Want to ask...
2021-09-1035 minBuilt with Biology: SpacesCatalog: Tracy KambaraHumans have been storing information since the Stone Age. And surprisingly, forms of data storage like painting or rock carving have lasted for millennia. The same cannot be said for more modern methods like cassettes and CDs. How can we store our data for the next millennia if our storage systems have shrinking functional lifespans?
Meet CATALOG, a company working to archive human data in DNA. DNA is one of the most stable molecules we know of and it has a language we can program. Hear how data is stored in DNA, what it takes to fit...
2021-09-0137 minBuilt with Biology: PodcastWhat Role Can Fragrances Play in Sustainability?Jasmine, musk, powder fresh; all our favorite fragrances typically come from petrochemicals. These scents are everywhere in daily life, from soaps and detergents to air fresheners, makeup, varnishes, the list is almost endless.
As we strive to make our everyday products sustainable, what do we do about our favorite scents? A joint team from biology companies Conagen and Sensegen is making sustainable fragrances with microbes.
How are these fragrance molecules made? How are scents designed by perfumers? Can biomanufactured perfumes aid animal welfare? Tune in to get all your questions answered!
2021-09-0127 minBuilt with Biology: SpacesPhytolon: Halim Jubran and Tal ZeltzerCandies, cakes, salad dressing, plant-based meats, butter; all these foods and so many more contain food coloring. Food coloring traditionally came from plants but today it comes from petrochemicals.
But now, the bioengineering company Phytolon has found a new way to make food colorings sustainably--and affordably!--using microbes!
Hear from Phytolon's founders about the science behind their breakthrough, how fabrics could be dyed with the same method, and how starting a company in Israel as Jewish and Arab co-founders is bringing communities and families together.
Want to ask your question live in one...
2021-08-3047 minBuilt with Biology: PodcastWhy Should Everyone Care About Biosecurity?Biology is reshaping our future, from our medicines to our food, fuels, homes, and even clothes.
But the power to engineer and re-design biology comes with significant responsibility.
How can we ensure the bio-engineering tools aren't misused or create accidentally harmful materials? How can we ensure workers, our society, and our planet are all protected?
In our inaugural Built with Biology Podcast episode, host Fiona Mischel speaks with James Diggans, Head of Biosecurity at Twist Bioscience. What is biosecurity, why does it matter, and how it could impact your day-to-day life? Get all...
2021-08-2437 min
BiofoundersRace Against the Clock ft. Seth Peachey"We wanted to move away from startup competitions and instead throw a massive welcome party to the bio-economy for everyone"--Seth@sethpeachey is a former startup founder, bitcoin super-enthusiast, and has a lot of experience in business development, especially in SaaS used for employee engagement.He is currently co-leading Race Against the Clock (RAC), an event organized by Synbiobeta and sponsored by Ginkgo Bioworks that aims to bring together future biotech founders who are (indeed) racing against the climate change clock.In this episode:· What Race Against t...
2021-08-1941 minBuilt with Biology: SpacesSolugen: Gaurab Chakrabarti and Sean HuntChemicals are fundamental in modern society, from the stability of our infrastructures and the safety of our water. But most of these critical materials typically come from petrochemical sources. Now Solugen, a biochemicals company using cell-free enzyme manufacturing, has made the world's first carbon-negative chemical plant for key water treatment ingredients.
Hear how the company has taken over an old petrochemical manufacturing plant in Texas, literally transforming the unsustainable methods of the past into the sustainable--and more cost-effective--methods of the future.
Want to ask your question live in one of our shows? Be sure to...
2021-08-1749 minBuilt with Biology: SpacesIndie Bio: Aja Labs & MicroTERRABuilding cool technology is all well and good but it's no good if it doesn't actually help our communities. Meet three powerful entrepreneurs who are solving problems with biology that so many others have overlooked or ignored.
Hear how Marissa Cuevas at MicroTerra is solving challenges for farmers with plant-based ingredients and how Osahon Ojeaga and Mary Ellen Moore at Aja Labs are creating plant-based hair extensions that help our planet and human rights. These IndieBio startups are blazing new trails with new leadership and new vision.
Want to ask your question live in one...
2021-08-1348 minBuilt with Biology: SpacesCulture Biosciences: Masaki Yamada and Kris TynerDo you have an idea of how to change the world with biology? Great! How are you going to know out if it works at scale in an affordable way? This is one of the big challenges Culture Biosciences is trying to solve with coffee-cup size bioreactors, cloud-based data, and remote lab capabilities.
Hear from Masaki Yamada and Kris Tyner, Product Manager and Senior Bioprocessessing Engineer discuss the challenges of scaling biomanufacturing, the impacts of COVID-19, their favorite applications of Culture's bioreactors, and much more!
Want to ask your question live in one of our...
2021-07-2841 min
Cê viu aquele artigo?Carnes de luxo feitas em laboratório - Episódio 01Nessa conversa João Gervásio e Yala Sampaio discutem sobre a ciência do cultivo de carnes e até onde essa promessa vai.
Matéria da Synbiobeta:
https://synbiobeta.com/next-on-the-menu-cellular-agriculture-could-domesticate-any-animal-on-the-planet/
2021-07-1916 minBuilt with Biology: SpacesJellatech: Stephanie MichelsenDo you love gummy bears? Or jello? Or your vitamin capsules? Ok, maybe not the last two but you probably also like wine. But what do these have in common? Gelatin and collagen.
These ingredients, which come from the leftovers of pig and cow slaughter for meat, are extremely useful but are currently not sustainable and are often unsafe for workers processing them.
Enter Jellatech, the first company in the world making these incredible ingredients using cellular agriculture. Hear Jellatech co-founder and CEO Stephanie Michelsen explore the science, opportunities, and teeny tiny cell-based gummy bears...
2021-07-1642 minBuilt with Biology: SpacesMammoth Biosciences: Janice ChenWhat is CRISPR? How does it work? Is it safe? How could this technology - one of the most powerful scientific tools of the 21st century - reshape our future, from the medicines we take to the foods we eat? Janice Chen, Chief Technology Officer of Mammoth Biosciences, explores the technology and envisions a future powered by CRISPR.
Want to ask your question live in one of our shows? Be sure to follow @SynBioBeta! #builtwithbiospaces
Keep in touch!
Fiona Mischel (Host)
@SynBioBeta@FionaRMischelhttps://synbiobeta.com/
Janice Chen
@janiceschen@mammothbioscihttps://mammoth...
2021-07-151h 02
2021-06-2500 min2021-06-2500 minBuilt with Biology: SpacesNautilus: Parag MallickWe spend a lot of time about DNA and the genome, all the genetic material in a living organism. But what about all the proteins? More unique and complex than DNA, proteins control much of how our bodies function and act as targets for therapeutics. Until recently, studying the proteome (all the proteins in an organism) was extremely difficult. Hear Parag Mallick from Nautilus tell the story of why everything may be about to change.
Want to ask your question live in one of our shows? Be sure to follow @SynBioBeta! #builtwithbiospaces
Keep in touch!
2021-06-1951 minBuilt with Biology: SpacesHerophilus : Saul Kato and Sharath HegdeWhy haven't therapeutics for brain diseases improved in decades? Could new approaches using brian organoids (aka mini-brains on a chip!) advance the field and bring potential cures to millions in need? Listen to Saul Kato and Sharath Hegde of Herophilus explain why inspirations of the past may point the way forward to a huge leap in treatments for brain disease.
Want to ask your question live in one of our shows? Be sure to follow @SynBioBeta! #builtwithbiospaces
Keep in touch!
Fiona Mischel (Host)
@SynBioBeta@FionaRMischelhttps://synbiobeta.com/
Herophilus:
@Herophilus_SFhttps...
2021-06-1656 minBuilt with Biology: SpacesDNA Script: Sylvain GarielWhat if you could make DNA in a box, put it on the back of a truck, take it to a hot zone, and start making vaccines directly at the epicenter of an emerging pandemic? That's exactly the kind of tech that Sylvain Gariel and the team at DNA Script are working on. Listen to how DNA can be made in a box using enzymes, where the DNA industry is headed, and much more
Want to ask your question live in one of our shows? Be sure to follow @SynBioBeta! #builtwithbiospaces
Keep in touch!
2021-06-1616 minBuilt with Biology: SpacesGenScript: Kay ChuangHow are the ingredients for CRISPR gene-editing technology like guide RNAs actually made? And what happened to the grad students trying to ship DNA to their house in the middle of a pandemic? Kay Chuang from GenScript shares great insights, surprising stories, and much more
Want to ask your question live in one of our shows? Be sure to follow @SynBioBeta! #builtwithbiospaces
Keep in touch!
Fiona Mischel (Host)
@SynBioBeta@FionaRMischelhttps://synbiobeta.com/
Kay Chuang:
@GenScripthttps://www.genscript.com/
Subscribe to the Built with Biology Digest for Spaces shows, news...
2021-06-1636 minBuilt with Biology: SpacesNuclera, Motif Foodworks, & ArtificialWelcome to the first episode of Built with Biology Spaces! Have you ever thought about how biology could change the world? Did you even know that it could? This week's guests are turning science fiction into reality!
Hear how biology is changing the world from artificial intelligence to digital microfluidics, to stretchy, melty plant-based cheese. Listen to guests Michael Chen from Nuclera, Dilek Uzunalioglu from Motif Foodworks , & Nikhita Singh from Artificial, share their stories, insights, and expertise!
Want to ask your question live in one of our shows? Be sure to follow @SynBioBeta! #builtwithbiospaces
2021-06-1650 minThe SynBioBeta PodcastWhat Will Our Technology Future Look Like? Star Trek vs Star Wars - with Matt OckoToday John Cumbers talks with Matt Ocko, co-founder and co-Managing Partner of the silicon valley deep tech venture fund DCVC. The topics for today are the different visions of the Star Trek and Star Wars future economies, the utopic versus the dystopic; how he evaluates a company in the context of these sci-fi classics; and why he has decided to invest in Deep Tech and what opportunities are emerging in synthetic biology.
Matt has over three decades of experience in the Deep Tech space, including computational and synthetic biology. Along with his investment work at DCVC, Matt h...
2021-06-1652 min
Space ExplrBiomedical Engineering, Synthetic Biology and Genetically Engineered Algae - ELLIOT ROTH | EP.94Elliot Roth is the founder of Spira, a company that creates replacements for animal and petroleum compounds in the supply chain using genetically engineered algae. Spira has received awards from RebelBio, Lighthouse Labs, the World Food Programme, Halcyon Incubator, BeGreen, CommBeBiz, and NSF. He has presented at South by Southwest, Synbiobeta, and Thought for Food. Elliot is a Kairos Fellow, a Seasteading Ambassador, and sat on the Virginia Governor’s Council for Youth Entrepreneurship. Before Spira, Elliot graduated with a degree in biomedical engineering. Where he studied synthetic biology for 12 years and worked for 5 years as a product consultant. He...
2021-05-141h 13
Marketplace TechInvestors are throwing money at mRNA and new medical technologies. What could go wrong?We've been talking about all the potential of mRNA technology — better vaccines and virus detection for all kinds of diseases. Now, let's talk about the money because the rush is on to invest in mRNA and the whole field of synthetic biology, which approaches the body and natural systems as programmable platforms like computers. However, the history of Silicon Valley and medical tech is mixed. You remember Theranos. Just last week, the founders of a once-hot biotech firm called uBiome were charged with fraud in a similar fashion. Molly speaks with John Cumbers, the founder of SynBioBeta, a network for en...
2021-03-2908 minCelestial CitizenAlgae-Based Innovation in SpaceAre you interested in the social impact of greater food security, access to nutritious ingredients, as well as, sustainable production methods both on Earth and in space?In this week's episode, I speak with Elliot Roth about his startup, Spira Inc., and how his team plans to disrupt the global supply chain by replacing harmful compounds with carbon-negative algae to create safer, locally-sourced products. We’ll also discuss how algae-based products can support humanity’s future in space, as well as, Elliot’s recent analog Moon mission with HI-SEAS on Mauna Loa in Hawaii.My guest...
2021-02-2553 minThe SynBioBeta PodcastHow nature co-design is changing the narrative - with Massimo PortincasoToday John Cumbers talks with Massimo Portincaso, managing director and partner at BCG. John will be talking to Massimo about what nature co-design, how we're shifting from global supply chains to global value chains, what distributed biological manufacturing is, and more..
Massimo Portincaso co-leads the Deep Tech Mission, BCG’s unit focused on the deep tech approach to innovation, emerging technologies, and the new rules of engagement for all actors in the innovation space. He is also the Chairman of Hello Tomorrow, an organization dedicated to unlocking the power of deep tech to solve the toughest global chall...
2021-02-0239 minThe SynBioBeta PodcastWhere brands and biology meet - with Karl SchmiederToday John Cumbers talks with Karl Schmieder the founder of messagingLAB, a strategy and consulting firm that helps biotechnology and synthetic biology companies create and execute strategies to drive the industry forward.
Connect with Karl: @karlschmieder
Connect with John: @johncumbers
Stay updated on the latest news in synthetic biology, check out our weekly newsletter and follow us on social media:
Twitter | LinkedIn | Facebook
Be sure you make it to SynBioBeta Brand and Biology event December 2nd & 3rd! Click here for more information.
2020-11-2530 min
Neurotech PubBiologists, Engineers, and LawyersWelcome to Neurotech Pub, hosted by Paradromics Inc and SynBioBeta. In this episode, host and Paradromics CEO, Matt Angle, speaks with Tim Harris, Cindy Chestek, and Philip "Flip" Sabes about the big programmatic challenges in neurotechnology. We talk about the differences between labs, startups, and large research consortia. We discuss the difference between neuroscience and neuroengineering, and Tim explains how one of the biggest breakthroughs in neurophysiology was the product of….lawyers.Check out full video with transcript here: https://www.paradromics.com/podcast/neurotech-pub-episode-1-biologists-engineers-and-lawyers 2:04 Jester King Brewery, Dripping Springs, TX | 3:03 Be...
2020-11-231h 32
Mendelspod PodcastSynBioBeta 2020 with John CumbersSynthetic biology was surging like perhaps no other bio-based industry when the pandemic struck, and it has had some unique weapons in its arsenal for aiding in the fight against COVID. There are the leading vaccine makers such as Moderna using synthetic biology, as well as antibody technology and CRISPR based testing. But many of the surging trends from the last year have only been made more urgent this year: small molecules, food tech, synthetic materials.Living with a pandemic is making humans more aware of our scientific dependence. This is a public episode. If you'd like...
2020-09-1532 minThe SynBioBeta PodcastDoes eating animals cause pandemics? - with Ryan Bethencourt of Wild EarthToday John Cumbers talks with Ryan Bethencourt, founder and CEO of Wild Earth. John will be talking to Ryan about the state of COVID and questions like "Does eating animals cause pandemics?"
Recorded live on: March 15th, 2020
To watch the video component: https://www.facebook.com/SynBioBeta/videos/199598178035525/
Connect with Ryan: @RyanBethencourt
Connect with John: @johncumbers
Stay updated on the latest news in synthetic biology, check out our weekly newsletter and follow us on social media:
Twitter | LinkedIn | Facebook
Be sure you make it to...
2020-08-261h 20The SynBioBeta PodcastHow DNA synthesis is powering the fourth manufacturing revolution - with Emily LeproustToday John Cumbers talks with Emily Leproust, Entrepreneur and CEO of Twist Bioscience. John will be talking to Emily about why she founded Twist, the many industries that will be disrupted by DNA technology, and how Twist is building a company culture for growth diversity and excellence.
Emily is the co founder and the CEO of Twist Bioscience, an early pioneer in high throughput synthesis and sequencing of DNA. Emily is disrupting the process of gene synthesis to enable the exponential growth of synthetic biology applications in many fields, including medicine, DNA, data storage, agriculture biology, and...
2020-08-1258 minThe SynBioBeta PodcastHow protein engineering is the killer app for biology - with John NicholsToday John Cumbers talks with John Nicols, President and CEO of Codexis, a leading protein engineering company here in Silicon Valley. I’ll be talking with John about “How protein engineering is the killer app for biology.” Specifically, I’ll talk with John about the amazing pedigree and origins of Codexis, how companies like Codexis are changing the way the biopharma industry does business, and John’s vision for how protein engineering is going to impact our daily lives.
Connect with John: @johncumbers
Stay updated on the latest news in synthetic biology, check out...
2020-08-051h 14
Pravidelná dávka157. Štyri bilióny dolárov ukryté v biológiiBioinžinierstvo a syntetická biológia nie sú len o bunkách a skúmavkách, ale aj o značnom ekonomickom prínose - prečo je to tak?
----more----
Prečítajte si túto dávku aj ako článok na SME: https://bit.ly/SME_davka157
Referencie
[1] New McKinsey Report Sees A $4 Trillion Gold Rush In This One Hot Sector. Who’s Selling Picks And Shovels? - SynBioBeta. (n.d.). Retrieved July 7, 2020, from https://synbiobeta.com/new-mckinsey-report-sees-a-4-trillion-gold-rush-in-this-one-hot-sector-whos-selling-picks-and-shovels/
[2] If Biology Can Build It, They Will Come: Ginkgo B...
2020-07-0710 min
Pravidelná dávka126. Vyrieši syntetická biológia problémy s klímou?V dnešnej epizóde Pravidelnej dávky Miro rozpráva o syntetickej biológii a o tom, ako syntetickí biológovia a niektoré zaujímavé spoločnosti v tejto oblasti môžu pomôcť riešiť problémy s klímou, ktorým všetci čelíme.
----more----
Môžeme upraviť baktérie tak, aby sa dokázali živiť skleníkovými plynmi z ovzdušia? A ako môžeme využiť metódy rastlinného inžinierstva? A čože to vlastne je tá syntetická biológia?
Vybrané Referencie
[1] http://sites.bu.edu/climate-change/
2020-02-2814 min
Pravidelná dávka102. O demokratizácii syntetickej biológie: s Keonim Gandallom zo StanforduMiro si do Pravidelnej dávky pozval Keoniho Gandalla, svojho kolegu z laboratória Prof. Drewa Endyho na Stanforde. Napriek tomu, že Keoni má len 20 rokov, už vedie projekt stavby a distribúcie dostupných génov do celého sveta. Články o ňom môžete nájsť napríklad vo Forbes a New York Times.
----more----
Rozprávajú sa aj o týchto otázkach:
Ako dať prístup ku genetickému inžinierstvu všetkým ľuďom podobne, ako dnes takmer každý má prístup k smartfónu? Ako vyriešiť logisticky distribúciu DNA po...
2019-11-221h 08
Petri DishCrispy CRISPRs and Gene Editing: Part 2Part two of CRISPR and genetic editing! This time, we talk about what plants and animals we have already CRISPR'd! Also, we discuss CRISPRs in the context of human health. Then, at the insistence of Nathan and Andrei, Sean is forced to discuss the ethical conundrums that come up surrounding the democratization of genetic modification. Nathan starts this episode out with a trigger warning about GMOs, but a less facetious trigger warning for this episode is that we discuss CRISPR and genetic modifications in the context of bioterrorism later in the episode (48:30-55:10), so if for whatever reason you find s...
2019-10-211h 03
The Bio ReportUsing Synthetic Biology to Build Intelligence into Cell and Gene TherapiesSenti Bio is using synthetic biology to build intelligence into cell and gene therapies, altering the way they act depending on the changing biological circumstances they may encounter in the body. Doing so may lead to safer and more effective therapies and address such things as the tumor microenvironment and mechanisms cancer have to grow, spread, and become resistant to treatments. Ahead of his appearance at the SynBioBeta conference that runs October 1-3 in San Francisco, we spoke to Tim Lu, co-founder and CEO of Senti Bio, about the company’s efforts to engineer a new class of intelligent medicines, it...
2019-09-2626 min
Future of AgricultureFOA 171: Synthetic Biology with Dr. John Cumbers of SynBioBeta Dr. John Cumbers is the founder of SynBioBeta. SynBioBeta prides itself as the premier innovation network for innovators, investors, entrepreneurs, and biological engineers. Their focus is introducing synthetic biology innovations to improve the human condition and make life more sustainable. John is a recipient of multiple grants and awards from NASA and the National Academy of Sciences for his work in the industry. He received his Ph.D. in Molecular Biology, Cell Biology, and Biochemistry from Brown University, his MSc in Bioinformatics from Edinburgh University, and a degree in Computer Science with Information Engineering from the University o...
2019-09-1833 min
Farm & Rural Ag NetworkFOA171 Synthetic Biology with Dr. John Cumbers of SynBioBetaFOA171 Synthetic Biology with Dr. John Cumbers of SynBioBeta Dr. John Cumbers is the founder of SynBioBeta. SynBioBeta prides itself as the premier innovation network for innovators, investors, entrepreneurs, and biological engineers. Their focus is introducing synthetic biology innovations to improve the human condition and make life more sustainable. John is a recipient of multiple grants and awards from NASA and the National Academy of Sciences for his work in the industry. He received his Ph.D. in Molecular Biology, Cell Biology, and Biochemistry from Brown University, his MSc in Bioinformatics from Edinburgh University, and a...
2019-09-1833 minThe SynBioBeta PodcastHow an artist becomes an investor and advisor to the world’s greatest technology companies - with D.A. WallachToday John Cumbers talks with D.A. Wallach, recording artist and emerging tech investor. John will be talking to D.A. about his journey from performing artist to investor in emerging tech, how his unique background informs his investment thesis, and what opportunities he’s most excited about in synthetic biology these days.
D.A. Wallach is a recording artist, songwriter, and investor. While an undergraduate at Harvard, he was discovered by Kanye West and Pharrell Williams. As a solo artist, D.A. is signed by Harvest Records, a subsidiary of Capitol Records, and he is...
2019-09-1152 minThe SynBioBeta PodcastHow this household name is beating climate change — and making great products - with Tom Dierking of P>oday John Cumbers talks with Tom Dierking, design director of transformational platform technologies at Procter & Gamble. John will be talking to Tom about his passion for transforming the consumer experience, Procter & Gamble’s revolutionary line of water-free products, and where he sees synthetic biology impacting the way that consumer brands do business.
Tom Dierking is the global design director of innovation capability at Procter & Gamble (P&G). He’s a passionate advocate of design and has been driving multidisciplinary innovation for over 20 years. In leading innovation at one of the world’s top brands, Tom’s work to...
2019-09-0438 min
Mendelspod Podcast'The Movement:' John Cumbers Previews the Rapidly Growing SynBioBeta 2019Synthetic biology is experiencing a second renaissance and the place to be this October 1-3 is at the SynBioBeta conference in San Francisco.For those of you who are going, today’s show is your preview. For those of you who need a nudge, just listen to what conference founder, John Cumbers, has conjured up in this biggest and most diverse lineup yet. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe
2019-09-0340 minThe SynBioBeta PodcastThe Mycelium Revolution: How a mushroom can make food, plastic, and more - with Eben Bayer of EcovativeFor the pictures John and Eben reference check out our website article (https://synbiobeta.com/synbiobeta-podcast-the-mycelium-revolution/)
Today John Cumbers talks with Eben Bayer, CEO and Co-Founder of the biomaterials company Ecovative. He’ll be talking with Eben about:
Why mycelium is an ideal host not just for biochemical production but also biomaterials structuring.Eben’s conception of “bio adaptation”, and the relationship of synthetic biology to “the good life.”What emerging products and markets he is most excited about these days, be it plastics, plant-based foods, or even the scaffolding for growing organs.
Ecovativ...
2019-08-2847 minThe SynBioBeta PodcastHow to spot a synthetic biology unicorn - with Ali Tamaseb of DCVCToday John Cumbers talks with Ali Tamaseb, an investor at the venture firm DCVC. John will be talking to Ali about his technical strategy for finding super-founders, emerging challenges for founders, particularly in synthetic biology, and what emerging market he is most excited about these days.
Ali is an entrepreneur, a previous startup founder, and a highly technical academic researcher. Ali has walked in the shoes of the scientist-turned-entrepreneur, and has first-hand experience with the challenges they face. At DCVC, he works on a broad spectrum of areas ranging from computational health and bio to c...
2019-08-2133 minThe SynBioBeta PodcastBuilding India's synthetic biology industry - with Santanu Dasgupta of RILToday John Cumbers talks with Dr. Santanu Dasgupta, Senior Vice President and Head of Biology at Reliance Industries Limited. John will be talking to Santanu about why algae is a great engineering platform, Reliance’s role in India’s arts, culture, and urban renewal, and the challenges to building the synthetic biology community in India
Santanu has more than 25 years in biotechnology research experience in various leadership roles. He has led many breakthrough global agriculture biotechnology programs, and has contributed to the discovery of numerous plant traits. He’s the author of several peer-reviewed papers and is...
2019-08-1439 minThe SynBioBeta PodcastThe role of creativity and design in biotechnology - with Christina Agapakis of Ginkgo BioworksToday John Cumbers talks to Dr. Christina Agapakis, biologist, writer, artist, and Creative Director at Ginkgo Bioworks. John will be talking to Christina about the role of creativity and design in biotechnology, what are Ginkgo’s top aims in terms of technology and its culture, and what kinds of opportunities she is most excited about today.
Christina serves as creative director at Ginkgo Bioworks, an organism design company that is bringing biology to industrial engineering. In that role, she collaborates with engineers, designers, artists, and social scientists to explore the many unexpected connections between microbiology, tec...
2019-08-0741 minThe SynBioBeta PodcastInvesting at the frontiers of life science innovation - with Jenny Rooke of Genoa VenturesToday John Cumbers talks to Dr. Jenny Rooke, the founder and Managing Director of Genoa Ventures, and one of Silicon Valley’s leading venture capitalists in the synthetic biology industry. John will be talking to Jenny about how VCs assess the value and potential of firms, what it takes to start your own VC firm, and what kinds of opportunities she is most excited about today.
For over a decade, Jenny has been deploying capital at the frontiers of life sciences innovation, seeking out technology-fueled solutions and category-defying opportunities. Jenny began her venture career at Fid...
2019-07-3133 minThe SynBioBeta PodcastSynthetic biology investing in an age of open platforms - with Ursheet Parikh of MayfieldToday John Cumbers talks to Ursheet Parikh, partner at Mayfield and leader of their biotechnology and health care portfolios. The conversation is about what it takes to scale synthetic biology companies, some of the challenges they face, and how platform technologies in synthetic biology can help float all boats.
Ursheet is a proven repeat entrepreneur and executive who brings 15 years of product and leadership experience to the investment team at Mayfield. He focuses on innovation that is redefining the application and infrastructure stacks in cloud, mobile, enterprise technologies, genomics and digital health.
...
2019-07-2443 minThe SynBioBeta PodcastProtein design 101 for synthetic biology - with Alexandre Zhanghellini of ArzedaToday John Cumbers talks to Alexandre Zanghellini, co-founder and CEO of Arzeda about Protein Design 101. Alex leads Arzeda’s product and technology development and IP strategy. He’s an inventor of Arzeda’s platform for computational protein design and more recently also branched into computational metabolic pathway design. Alex will
introduce protein design, discuss automation and technical advancement, touch on a few applications, and the potential of protein design to improve the world and bring new products to market.
Thanks to Arzeda for making this episode possible.
Connect with Alex:
2019-07-1741 minThe SynBioBeta PodcastHow to tell your synthetic biology story - with Ben Kellogg of BWKJohn Cumbers talks to Ben Kellogg about telling a compelling synthetic biology story. Ben is the founder of BWK, an award-winning PR consulting firm representing clients like TED, MIT, Modern Meadow and Culture Biosciences. As the PR partner to TED’s Fellowship program, BWK works directly with the 400+ TED Fellows including scientists, technologists, artists and entrepreneurs. Ben graduated from Yale with a degree in English and has a decade of experience advising executives and entrepreneurs on their PR communications strategy.
Connect with Ben:
Connect with John...
2019-07-1030 min
Learning With LowellGrowing Spirulina, Yourself, and 100 Day Challenges with CEO and Founder Elliot Roth (Part 1)Blue man group, agriculture, feeding the world, algae, Egyptian stages of death, finding a fulfilling purpose in life, 100 day challenges, value of building in LA, how he got started and has been developing his company, book and resource recommendations, hiring people, FBI bioterrorism, and much much much more in this 2 hour interview with this weeks guest Elliot Roth CEO of Spira. This episode is one you won't want to miss!
About Elliot
"Elliot is incredibly motivated to solve physiological needs using simple biological design.
After being trained as a University Innovation Fellow at the Stanford d.School, Elliot started multiple...
2019-07-101h 04The SynBioBeta PodcastWelcome to the SynBioBeta Podcast!The SynBioBeta Podcast is here!
Subscribe now. Episode 1 debuts July 10th.
Conversations with synthetic biology’s leading thinkers on building a better world with biology. The podcast is hosted by John Cumbers, founder and CEO of SynBioBeta, where tech meets bio and bio meets tech.
Stay updated on the latest news in synthetic biology, check out our weekly newsletter and follow us on social media:
Twitter | LinkedIn | Facebook
Be sure you make it to SynBioBeta 2019 this October 1-3! Click here for more information.
2019-07-0301 minLearning With Lowell51: Scaling DNA Circuit Tests Under 30 minutes, Challenges with that, Startup story with Dr. Thomas the CEO and Founder of Cell Free and Open Cell in the UKHow to build a factory to automate processes, Scaling DNA circuits tests to be able to be done in under 30 minutes, why now is the prefect time for Cell Free to exist, a bit on his founding story and struggles, and great rapid fire questions at the end!
CEO of Cell Free and Director of Open Cell Dr.Thomas Meany
"As a former interdisciplinary Research Fellow at Cambridge, Tom spent his career working closely and across academia, industry, nanoelectronics & synthetic biology." From Website
Cell Free
"we develop practical tools for industry, researchers and individuals who wish to test and trial biologi...
2018-08-2136 min
Entrepreneur Before 25115: How pond scum can change the world with Elliot Roth This title is no joke... Elliot Roth is the founder of Spira- a company that genetically engineers spirulina for food ingredients. Spira has received awards from RebelBio, Lighthouse Labs, the World Food Programme, Halcyon Incubator, BeGreen, CommBeBiz, and National Science Foundation, and has presented at SXSW, Synbiobeta and Thought for Food. Elliot uses his genius inventions and scientific engineering of Spira to accomplish his purpose and passion in life- to solve physiological needs using simple biological design. Resources: Connect with Elliot further: Facebook | Instagram Email Elliot personally at: elliot@livespira.c...
2018-08-0843 min
"Can't Be Done"Ep. 34: Helping Scientists Become Entrepreneurs with Arvind Gupta of IndieBioWhat happens when you marry a background in genetic engineering with extensive experience in design? A unique skill set that supports life scientists in becoming entrepreneurs, helping PhDs turn benchtop science into applied products with the potential to change lives.
Arvind Gupta is the co-founder of IndieBio, the world’s largest seed biotech accelerator. He has over a decade of experience helping startups and Fortune 50 companies launch new tech products, and his thought-leadership has been published in Time, Design Observer, and Rotman Management Magazine, among others. Arvind has received a number of international awards for design and in...
2017-11-1627 min